Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tracking Lipid-Lowering Therapy Over One Year in Middle Eastern Patients With ASCVD. The Jordan LLA Tracking Study

NCT05629767 is registered in ClinicalTrials.gov with Jordan Collaborating Cardiology Group as lead sponsor.

NCT NCT05629767
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05629767 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tracking Lipid-Lowering Therapy Over One Year in Middle Eastern Patients With ASCVD. The Jordan LLA Tracking Study
Lead sponsor
Jordan Collaborating Cardiology Group
Phase
Observational
Overall status
Terminated
Start date
December 11, 2022
Completion date
January 2, 2024
Enrollment
1,000 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerotic cardiovascular disease, dyslipidemias